• Ipsos
  • Insights Hub
  • Targeting the Affluent: Differential Access to Targeted Therapies in China

Targeting the Affluent: Differential Access to Targeted Therapies in China

Conquering Complexity, at a Price. This paper will illustrate how disparities in income levels continue to drive far-reaching differences in the way poorer and richer Chinese with cancer are being treated for their disease.

The war against cancer is now being fought at a molecular level – harnessing the insights we have gained into the complexity of our enemy. However, this revolution is, quite literally, coming at a price. This new molecular battlefront isn’t just complex; it is incredibly hungry for money.

Different countries around the world have adopted the new tactics and tools at varying speeds and with markedly different levels of success. In particular, there is substantial variability between different countries’ ability to ensure equal access to the most effective – and often the most expensive – drug treatments for all citizens diagnosed with cancer.

Using data from the Ipsos Global Oncology Monitor ©, Pieter De Richter – Head of Real World Evidence in APAC and MENA – looks in-depth at China, exploring the differential access to anti-cancer therapies in this key Asian market.

Download

The author(s)

  • Pieter De Richter
    Pieter De Richter
    Regional Service Line Leader, Healthcare in APAC, Malaysia

More insights about Health

Related news

  • KEYS: Our World in Motion
    E mobility Webinar

    [Webinar] KEYS: Our World in Motion

    At our next KEYS webinar, we’ll be launching the inaugural Ipsos Mobility Report.
  • [Webinar] Real evidence from real experiences: Patient Centric Evidence
    Healthcare Webinar

    [Webinar] Real evidence from real experiences: Patient Centric Evidence

    Regulators, payers and clinicians are asking for more than traditional real world evidence (RWE). They want to understand how treatments affect people’s daily lives - not just what is written in the case report form. But how can you build patient-centric evidence that stands up to scientific, regulatory and commercial scrutiny?
  • Battle For Attention - KEYS Webinar from Ipsos
    Communications Events replay

    [Webinar] KEYS: Battle For Attention

    In today’s hyper-fragmented landscape, communicating using short-form content and social media platforms is an essential part of our toolkit. But are they better suited to short-term engagement rather than long-term brand building? And what does genuinely innovative and creative advertising look like these days?